Karuna Therapeutics to Present at Upcoming Investor Conferences

Published

BOSTON--(BUSINESS WIRE)-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the following upcoming investor conferences:

Guggenheim 5th Annual Inflammation & Immunology Conference Date: Tuesday, November 7, 2023 Time: 1:50 p.m. ET

Stifel 2023 Healthcare Conference Date: Tuesday, November 14, 2023 Time: 8:35 a.m. ET

A live webcast of the presentations will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the completion of each event.

About Karuna

Karuna Therapeutics is a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

Investors: Alexis Smith +1 (617) 352-9917 asmith@karunatx.com

Media: Julie Ciardiello +1 (917) 647-0159 julie.ciardiello@karunatx.com

Source: Karuna Therapeutics, Inc.

In This Story

KRTX